“The Impact of Chimeric Antigen Receptor (CAR) T Cell Therapy: Its Potential to Reshape Rheumatology Practice” (2025) Canadian Rheumatology Today, 2(1), pp. 30–36. doi:10.58931/crt.2025.2160.